On 3/18/25, Sarepta Therapeutics Inc (NASDAQ: SRPT) stock suffered a major decline of -27.4%, closing at $73.54. Moreover, this decline was accompanied by exceptionally high trading volume at 1107% of normal. Relative to the market the stock has been weak over the last nine months and has declined -26.2% during the last week.
Current PriceTarget Research Rating
Sarepta Therapeutics has a current Value Trend Rating of C (Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Sarepta Therapeutics has a very high Appreciation Score of 96 but a very low Power Rating of 6, triggering the Neutral Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment